Gaudium IVF IPO
IPO Date: 20-24 Feb
Gaudium IVF IPO open date is February 20,2026 and the IPO will close on February 24,2026. Gaudium IVF IPO is a Book build Issue. The company to raise around ₹165 crores via IPO that comprises fresh issue of ₹90 crores and offer for sale up to 94,93,700 equity shares with face value of ₹5 each. Gaudium IVF IPO price band is ₹75 to ₹79 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Gaudium IVF IPO to list on BSE NSE on February 27,2026.
Price Band
₹79
Listing Exchange
Mainboard
Total Subscription
0.89x
Status
processed
Gaudium IVF IPO Details
Gaudium IVF IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | February 20,2026 |
| IPO Close Date | February 24,2026 |
| Basis of Allotment | February 25,2026 |
| Refunds | February 26,2026 |
| Credit to Demat Account | February 26,2026 |
| IPO Listing Date | February 27,2026 |
| IPO Bidding Cut-off Time | February 24,2026 – 5 PM |
Gaudium IVF IPO Market Lot
The Gaudium IVF IPO minimum market lot is 189 shares with ₹14,931 application amount. The retail investors can apply up to 13 lots with 2,457 shares of ₹1,94,103 amount.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 189 | ₹14,931 |
| Retail Maximum | 13 | 2,457 | ₹1,94,103 |
| S-HNI Minimum | 14 | 2,646 | ₹2,09,034 |
| S-HNI Maximum | 66 | 12,474 | ₹9,85,446 |
| B-HNI Minimum | 67 | 12,663 | ₹10,00,377 |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor | – Shares |
| QIB (Ex. Anchor) | – Shares |
| NII Shares Offered | – Shares |
| Retail Shares Offered | – Shares |
| Promoter Holding Pre Issue | 6,13,94,384 |
| Promoter Holding Post Issue | 7,27,86,884 |
Anchor Investor Details
| Detail | Value |
|---|---|
| Shares Offered | 62,65,860 Shares |
| Anchor Size | 49.50 Cr. |
| lock-in period end date 50% shares (30 Days) | March 27,2026 |
| lock-in period end date 50% shares (90 Days) | May 26,2026 |
Objects of the Issue
| Purpose | ₹ in Crores |
|---|---|
| Funding capital expenditure towards establishment of New IVF Centers of the Company | ₹50 |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and | ₹20 |
About Gaudium IVF
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization IVF treatments for women across India. The company operates its business over 30 locations, with seven hubs centres and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
Gaudium IVF IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹44.26 | ₹25.95 | ₹13.53 | ₹36.63 |
| 2024 | ₹48.15 | ₹31.52 | ₹10.32 | ₹51.01 |
| 2025 | ₹70.96 | ₹45.54 | ₹19.13 | ₹88.51 |
| Sep 2025 | ₹49.75 | ₹32.97 | ₹12.51 | ₹106.62 |
Gaudium IVF IPO Key Ratios
Check Gaudium IVF IPO valuations detail like Earning Per Share EPS, PriceEarning PE Ratio, Return on Net Worth RoNW, and Net Asset Value NAV details.
| KPI | Values |
|---|---|
| ROE | 41.31% |
| ROCE | 39.70% |
| EBITDA Margin | 40.48% |
| PAT Margin | 26.96% |
| Debt to equity ratio | 0.41 |
| Earning Per Share (EPS) | ₹3.12 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 41.71% |
| Net Asset Value (NAV) | ₹7.54 |
Gaudium IVF IPO Subscription Status
| QIB | NII | Retail | Total |
|---|---|---|---|
| 0.00x | 0.91x | 1.39x | 0.89x |
Subscription data as reported by exchange records. Updated as of 22 Feb 2026, 2:58 pm.
Promoters & Holding
Promoters of the company:
- Dr. Manika Khanna
- Dr. Peeyush Khanna
- Vishad Khanna
Key Dates
The Gaudium IVF IPO date is February 20, and the close date is February 24. The Gaudium IVF IPO allotment will be finalized on February 2,5 and the IPO listing on February 27.
Company Address
Gaudium IVF Womens Health Ltd.
B151, Janak Puri, B-1, New Delhi, New Delhi, 110058
Registrar Information
Bigshare Services Pvt. Ltd.
Registrar identity is sourced from official exchange filings. This platform is not affiliated with the registrar.
Additional Information
| Detail | Value |
|---|---|
| Anchor Bidding Date | February 19,2026 |
Risk Factors & Important Notices
• Investing in IPOs involves risks. Past performance of similar companies does not guarantee future results.
• IPO allotment is subject to availability and regulatory requirements.
• Investors should read the Red Herring Prospectus (RHP) and other official documents carefully before applying.
• Consult a SEBI-registered financial advisor for personalized investment guidance.
• Stock prices post-listing can fluctuate significantly based on market conditions.
DISCLAIMER: None of the financial information published herein should be construed as an offer to buy or sell securities or as advice in any way. All information published herein is for educational and informational purposes only and should not be relied upon as a basis for investment decisions under any circumstances. Readers must consult a qualified financial advisor before making any actual investment decisions. Grey Market Premium (GMP) is unofficial and unregulated. Always trade through official, regulated channels.
⚠Unofficial Market Sentiment (Educational Only)
Grey market information — not investment advice. Collapsed by default.
▼
Unofficial Market Sentiment (Educational Only)
Grey market information — not investment advice. Collapsed by default.
⚠ Important Notice
• GMP is unregulated, third-party sentiment. It may be inaccurate.
• This platform does not verify or endorse any GMP figure.
• Investment decisions should never be based on grey market premiums alone.
• Always consult a SEBI-registered financial advisor before investing.
Grey Market Premium (GMP)
⚠ Unofficial₹8⚠ unregulated, third-party sentiment — may be inaccurate
Last retrieved: 22 Feb 2026, 2:58 pm
Data Source & Methodology
GMP values displayed on this platform are aggregated from publicly available discussions, forums, and community-reported data. They represent unverified, third-party market sentiment and are provided for informational and educational purposes only. This platform does not independently verify, endorse, or guarantee the accuracy of any GMP figure.
Registrar information sourced from official exchange filings. This platform is not affiliated with, endorsed by, or acting on behalf of any IPO registrar. All unofficial market sentiment data is clearly separated and labeled accordingly.